Understanding Pre-Eclampsia Using Alzheimer's Etiology: An Intriguing Viewpoint

American Journal of Reproductive Immunology

Volumn 75, Issue 3, 2016, Pages 372-381

  Cheng, Shi Bin ^a   Nakashima, Akitoshi ^a   Sharma, Surendra ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Amyloid precursor protein; autophagy; endoplasmic reticulum stress; pre eclampsia; protein misfolding and aggregation disease; transthyretin

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; PREALBUMIN;

ALZHEIMER DISEASE; FEMALE; GESTATIONAL AGE; HUMAN; PATHOPHYSIOLOGY; PLACENTA; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEOMICS; REVIEW;

EID: 84977570924     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/aji.12446     Document Type: Review

References (87)

1. Chaiworapongsa T, Chaemsaithong P, Yeo L, Romero R: Pre-eclampsia part 1: current understanding of its pathophysiology. Nat Rev Nephrol 2014; 10:466–480.
2. Goel A, Rana S: Angiogenic factors in preeclampsia: potential for diagnosis and treatment. Curr Opin Nephrol Hypertens 2013; 22:643–650.
3. Hagmann H, Thadhani R, Benzing T, Karumanchi SA, Stepan H: The promise of angiogenic markers for the early diagnosis and prediction of preeclampsia. Clin Chem 2012; 58:837–845.
4. Roberts JM, Hubel CA: Is oxidative stress the link in the two-stage model of pre-eclampsia? Lancet 1999; 354:788–789.
5. Redman CW, Sargent IL: Latest advances in understanding preeclampsia. Science 2005; 308:1592–1594.
6. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R: Pre-eclampsia. Lancet 2010; 376:631–644.
7. Sunderland N, Hennessy A, Makris A: Animal models of pre-eclampsia. Am J Reprod Immunol 2011; 65:533–541.
8. Roberts JM, Bell MJ: If we know so much about preeclampsia, why haven't we cured the disease? J Reprod Immunol 2013; 99:1–9.
9. Chesley LC: Hypertensive Disorders of Pregnancy. New York, Appleton-Century-Crofts, 1978.
10. Dekker G, Sibai B: Primary, secondary, and tertiary prevention of pre-eclampsia. Lancet 2001; 357:209–215.
11. Kalkunte S, Boij R, Norris W, Friedman J, Lai Z, Kurtis J, Lim KH, Padbury JF, Matthiesen L, Sharma S: Sera from preeclampsia patients elicit symptoms of human disease in mice and provide a basis for an in vitro predictive assay. Am J Pathol 2010; 177:2387–2398.
12. Kalkunte SS, Neubeck S, Norris WE, Cheng SB, Kostadinov S, Vu Hoang D, Ahmed A, von Eggeling F, Shaikh Z, Padbury J, Berg G, Olofsson A, Markert UR, Sharma S: Transthyretin is dysregulated in preeclampsia, and its native form prevents the onset of disease in a preclinical mouse model. Am J Pathol 2013; 183:1425–1436.
13. Kalkunte S, Lai Z, Norris WE, Pietras LA, Tewari N, Boij R, Neubeck S, Markert UR, Sharma S: Novel approaches for mechanistic understanding and predicting preeclampsia. J Reprod Immunol 2009; 83:134–138.
14. Labbadia J, Morimoto RI: The biology of proteostasis in aging and disease. Annu Rev Biochem 2015; 84:435–464.
15. Mukherjee A, Morales-Scheihing D, Butler PC, Soto C: Type 2 diabetes as a protein misfolding disease. Trends Mol Med 2015; 21:439–449.
16. Soto C: Unfolding the role of protein misfolding in neurodegenerative diseases. Nat Rev Neurosci 2003; 4:49–60.
17. Li X, Buxbaum JN: Transthyretin and the brain re-visited: is neuronal synthesis of transthyretin protective in Alzheimer's disease? Mol Neurodegener 2011; 6:79.
18. Fong VH, Vieira A: Transthyretin aggregates induce production of reactive nitrogen species. Neurodegener Dis 2013; 11:42–48.
19. Nunes RJ, de Oliveira P, Lages A, Becker JD, Marcelino P, Barroso E, Perdigoto R, Kelly JW, Quintas A, Santos SC: Transthyretin proteins regulate angiogenesis by conferring different molecular identities to endothelial cells. J Biol Chem 2013; 288:31752–31760.
20. Obayashi K, Ando Y, Nakamura M, Terazaki H, Yamashita T, Tashima K, Suga M, Uchino M, Ando M: Endothelium-dependent vasodilatation in patients with familial amyloidotic polyneuropathy. Muscle Nerve 2000; 23:1084–1088.
21. Reixach N, Deechongkit S, Jiang X, Kelly JW, Buxbaum JN: Tissue damage in the amyloidoses: transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture. Proc Natl Acad Sci USA 2004; 101:2817–2822.
22. Sakashita N, Ando Y, Jinnouchi K, Yoshimatsu M, Terazaki H, Obayashi K, Takeya M: Familial amyloidotic polyneuropathy (ATTR Val30Met) with widespread cerebral amyloid angiopathy and lethal cerebral hemorrhage. Pathol Int 2001; 51:476–480.
23. Buhimschi IA, Nayeri UA, Zhao G, Shook LL, Pensalfini A, Funai EF, Bernstein IM, Glabe CG, Buhimschi CS: Protein misfolding, congophilia, oligomerization, and defective amyloid processing in preeclampsia. Sci Transl Med 2014; 6:245ra92.
24. Chen CW, Jaffe IZ, Karumanchi SA: Pre-eclampsia and cardiovascular disease. Cardiovasc Res 2014; 101:579–586.
25. Vest AR, Cho LS: Hypertension in pregnancy. Curr Atheroscler Rep 2014; 16:395.
26. Al-Jameil N, Aziz Khan F, Fareed Khan M, Tabassum H: A brief overview of preeclampsia. J Clin Med Res 2014; 6:1–7.
27. Lai Z, Kalkunte S, Sharma S: A critical role of interleukin-10 in modulating hypoxia-induced preeclampsia-like disease in mice. Hypertension 2011; 57:505–514.
28. Germain SJ, Sacks GP, Soorana SR, Sargent IL, Redman CW: Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles. J Immunol 2007; 178:5949–5956.
29. Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, Bdolah Y, Lim KH, Yuan HT, Libermann TA, Stillman IE, Roberts D, D'Amore PA, Epstein FH, Sellke FW, Romero R, Sukhatme VP, Letarte M, Karumanchi SA: Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006; 12:642–649.
30. Muralimanoharan S, Maloyan A, Mele J, Guo C, Myatt LG, Myatt L: MIR-210 modulates mitochondrial respiration in placenta with preeclampsia. Placenta 2012; 33:816–823.
31. Chen Q, Shen F, Wei J, Stone P, Snowise S, Chamley L: Trophoblast microparticles from placental explants treated with preeclampsia sera activate endothelial cells: possible relevance to the pathogenesis of preeclampsia. Placenta 2013; 34:A1–A99.
32. Redman CW, Sargent IL: Placental stress and pre-eclampsia: a revised view. Placenta 2009; 30(Suppl A):S38–S42.
33. Cindrova-Davies T: Gabor Than Award Lecture 2008: pre-eclampsia – from placental oxidative stress to maternal endothelial dysfunction. Placenta 2009; 30(Suppl A):S55–S65.
34. Redman CW: The endoplasmic reticulum stress of placental impoverishment. Am J Pathol 2008; 173:311–314.
35. Yung HW, Calabrese S, Hynx D, Hemmings BA, Cetin I, Charnock-Jones DS, Burton GJ: Evidence of placental translation inhibition and endoplasmic reticulum stress in the etiology of human intrauterine growth restriction. Am J Pathol 2008; 173:451–462.
36. Burton GJ, Yung HW, Cindrova-Davies T, Charnock-Jones DS: Placental endoplasmic reticulum stress and oxidative stress in the pathophysiology of unexplained intrauterine growth restriction and early onset preeclampsia. Placenta 2009; 30(Suppl A):S43–S48.
37. Burton GJ, Yung HW: Endoplasmic reticulum stress in the pathogenesis of early-onset pre-eclampsia. Pregnancy Hypertens 2011; 1:72–78.
38. Burton GJ, Yung HW, Cindrova-Davies T, Charnock-Jones DS: Placental endoplasmic reticulum stress and oxidative stress in the pathophysiology of unexplained intrauterine growth restriction and early onset preeclampsia. Placenta 2009; 30(Suppl A):S43–S48.
39. Gao HJ, Zhu YM, He WH, Liu AX, Dong MY, Jin M, Sheng JZ, Huang HF: Endoplasmic reticulum stress induced by oxidative stress in decidual cells: a possible mechanism of early pregnancy loss. Mol Biol Rep 2012; 39:9179–9186.
40. Jones CJ, Fox H: An ultrastructural and ultrahistochemical study of the human placenta in maternal pre-eclampsia. Placenta 1980; 1:61–76.
41. Kawakami T, Yoshimi M, Kadota Y, Inoue M, Sato M, Suzuki S: Prolonged endoplasmic reticulum stress alters placental morphology and causes low birth weight. Toxicol Appl Pharmacol 2014; 275:134–144.
42. Lian IA, Løset M, Mundal SB, Fenstad MH, Johnson MP, Eide IP, Bjørge L, Freed KA, Moses EK, Austgulen R: Increased endoplasmic reticulum stress in decidual tissue from pregnancies complicated by fetal growth restriction with and without pre-eclampsia. Placenta 2011; 32:823–829.
43. Jain A, Olovsson M, Burton GJ, Yung HW: Endothelin-1 induces endoplasmic reticulum stress by activating the PLC-IP(3) pathway: implications for placental pathophysiology in preeclampsia. Am J Pathol 2012; 180:2309–2320.
44. Hagmann H, Bossung V, Belaidi AA, Fridman A, Karumanchi SA, Thadhani R, Schermer B, Mallmann P, Schwarz G, Benzing T, Brinkkoetter PT: Low-molecular weight heparin increases circulating sFlt-1 levels and enhances urinary elimination. PLoS One 2014; 9:e85258.
45. Rana S, Karumanchi SA, Lindheimer MD: Angiogenic factors in diagnosis, management, and research in preeclampsia. Hypertension 2014; 63:198–202.
46. Rana S, Schnettler WT, Powe C, Wenger J, Salahuddin S, Cerdeira AS, Verlohren S, Perschel FH, Arany Z, Lim KH, Thadhani R, Karumanchi SA: Clinical characterization and outcomes of preeclampsia with normal angiogenic profile. Hypertens Pregnancy 2013; 32:189–201.
47. Wallace MR, Naylor SL, Kluve-Beckerman B, Long GL, McDonald L, Shows TB, Benson MD: Localization of the human prealbumin gene to chromosome 18. Biochem Biophys Res Commun 1985; 129:753–758.
48. Liz MA, Faro CJ, Saraiva MJ, Sousa MM: Transthyretin, a new cryptic protease. J Biol Chem 2004; 279:21431–21438.
49. Fleming CE, Mar FM, Franquinho F, Saraiva MJ, Sousa MM: Transthyretin internalization by sensory neurons is megalin mediated and necessary for its neuritogenic activity. J Neurosci 2009; 29:3220–3232.
50. Buxbaum JN, Ye Z, Reixach N, Friske L, Levy C, Das P, Golde T, Masliah E, Roberts AR, Bartfai T: Transthyretin protects Alzheimer's mice from the behavioral and biochemical effects of Abeta toxicity. Proc Natl Acad Sci USA 2008; 105:2681–2686.
51. Cascella R, Conti S, Mannini B, Li X, Buxbaum JN, Tiribilli B, Chiti F, Cecchi C: Transthyretin suppresses the toxicity of oligomers formed by misfolded proteins in vitro. Biochim Biophys Acta 2013; 1832:2302–2314.
52. Li X, Zhang X, Ladiwala AR, Du D, Yadav JK, Tessier PM, Wright PE, Kelly JW, Buxbaum JN: Mechanisms of transthyretin inhibition of beta-amyloid aggregation in vitro. J Neurosci 2013; 33:19423–19433.
53. Palaninathan SK, Mohamedmohaideen NN, Snee WC, Kelly JW, Sacchettini JC: Structural insight into pH-induced conformational changes within the native human transthyretin tetramer. J Mol Biol 2008; 382:1157–1167.
54. Sipe JD, Benson MD, Buxbaum JN, Ikeda S, Merlini G, Saraiva MJ, Westermark P: Nomenclature 2014: amyloid fibril proteins and clinical classification of the amyloidosis. Amyloid 2014; 21:221–224.
55. Sousa MM, Cardoso I, Fernandes R, Guimarães A, Saraiva MJ: Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy – evidence for toxicity of nonfibrillar aggregates. Am J Pathol 2001; 159:1993–2000.
56. Andersson K, Olofsson A, Nielsen EH, Svehag SE, Lundgren E: Only amyloidogenic intermediates of transthyretin induce apoptosis. Biochem Biophys Res Commun 2002; 294:309–314.
57. McKinnon B, Li H, Richard K, Mortimer R: Synthesis of thyroid hormone binding proteins transthyretin and albumin by human trophoblast. J Clin Endocrinol Metab 2005; 90:6714–6720.
58. Patel J, Landers KA, Li H, Mortimer RH, Richard K: Ontogenic changes inplacental transthyretin. Placenta 2011; 32:817–822.
59. Vascotto C, Salzano AM, D'Ambrosio C, Fruscalzo A, Marchesoni D, di Loreto C, Scaloni A, Tell G, Quadrifoglio F: Oxidized transthyretin in amniotic fluid as an early marker of preeclampsia. J Proteome Res 2007; 6:160–170.
60. Chan SY, Vasilopoulou E, Kilby MD: The role of the placenta in thyroid hormone delivery to the fetus. Nat Clin Pract Endocrinol Metab 2009; 5:45–54.
61. Hardy JA, Higgins GA: Alzheimer's disease: the amyloid cascade hypothesis. Science 1992; 256:184–185.
62. Hardy J: The amyloid hypothesis for Alzheimer's disease: a critical reappraisal. J Neurochem 2009; 110:1129–1134.
63. Nalivaeva NN, Turner AJ: The amyloid precursor protein: a biochemical enigma in brain development, function and disease. FEBS Lett 2013; 587:2046–2054.
64. Zhang H, Ma Q, Zhang YW, Xu H: Proteolytic processing of Alzheimer's β-amyloid precursor protein. J Neurochem 2012; 120(Suppl 1):9–21.
65. O'Brien RJ, Wong PC: Amyloid precursor protein processing and Alzheimer's disease. Annu Rev Neurosci 2011; 34:185–204.
66. Nunan J, Small DH: Regulation of APP cleavage by alpha-, beta- and gamma-secretases. FEBS Lett 2000; 483:6–10.
67. Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, Glabe CG: Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 2003; 300:486–489.
68. Larson ME, Lesné SE: Soluble Aβ oligomer production and toxicity. J Neurochem 2012; 120(Suppl 1):125–139.
69. Glabe CG: Common mechanisms of amyloid oligomer pathogenesis in degenerative disease. Neurobiol Aging 2006; 27:570–575.
70. Aguzzi A, O'Connor T: Protein aggregation diseases: pathogenicity and therapeutic perspectives. Nat Rev Drug Discov 2010; 9:237–248.
71. Li X, Zhang K, Li Z: Unfolded protein response in cancer: the physician's perspective. J Hematol Oncol 2011; 4:8.
72. Jian B, Hsieh CH, Chen J, Choudhry M, Bland K, Chaudry I, Raju R: Activation of endoplasmic reticulum stress response following trauma-hemorrhage. Biochim Biophys Acta 2008; 1782:621–626.
73. Mao XR, Crowder CM: Protein misfolding induces hypoxic preconditioning via a subset of the unfolded protein response machinery. Mol Cell Biol 2010; 30:5033–5042.
74. Zhou J, Xiao D, Hu Y, Wang Z, Paradis A, Mata-Greenwood E, Zhang L: Gestational hypoxia induces preeclampsia-like symptoms via heightened endothelin-1 signaling in pregnant rats. Hypertension 2013; 62:599–607.
75. Rueda-Clausen CF, Stanley JL, Thambiraj DF, Poudel R, Davidge ST, Baker PN: Effect of prenatal hypoxia in transgenic mouse models of preeclampsia and fetal growth restriction. Reprod Sci 2014; 21:492–502.
76. Raghupathy R: Cytokines as key players in the pathophysiology of preeclampsia. Med Princ Pract 2013; 22(Suppl 1):8–19.
77. Cuanalo-Contreras K, Mukherjee A, Soto C: Role of protein misfolding and proteostasis deficiency in protein misfolding diseases and aging. Int J Cell Biol 2013; 2013:638083.
78. Gardner BM, Pincus D, Gotthardt K, Gallagher CM, Walter P: Endoplasmic reticulum stress sensing in the unfolded protein response. Cold Spring Harb Perspect Biol 2013; 5:a013169.
79. Suresh A, Subedi K, Kyathanahalli C, Jeyasuria P, Condon JC: Uterine endoplasmic reticulum stress and its unfolded protein response may regulate caspase 3 activation in the pregnant mouse uterus. PLoS One 2013; 8:e75152.
80. Hung TH, Hsieh TT, Chen SF, Li MJ, Yeh YL: Autophagy in the human placenta throughout gestation. PLoS One 2013; 8:e83475.
81. Liu C, Gao Y, Barrett J, Hu B: Autophagy and protein aggregation after brain ischemia. J Neurochem 2010; 115:68–78.
82. Luo T, Park Y, Sun X, Liu C, Hu B: Protein misfolding, aggregation, and autophagy after brain ischemia. Transl Stroke Res 2013; 4:581–588.
83. Hung TH, Chen SF, Lo LM, Li MJ, Yeh YL, Hsieh TT: Increased autophagy in placentas of intrauterine growth-restricted pregnancies. PLoS One 2012; 7:e40957.
84. Oh SY, Choi SJ, Kim KH, Cho EY, Kim JH, Roh CR: Autophagy-related proteins, LC3 and Beclin-1, in placentas from pregnancies complicated by preeclampsia. Reprod Sci 2008; 15:912–920.
85. Saito S, Nakashima A: A review of the mechanism for poor placentation in early-onset preeclampsia: the role of autophagy in trophoblast invasion and vascular remodeling. J Reprod Immunol 2014; 101–102:80–88.
86. Nakashima A, Yamanaka-Tatematsu M, Fujita N, Koizumi K, Shima T, Yoshida T, Nikaido T, Okamoto A, Yoshimori T, Saito S: Impaired autophagy by soluble endoglin, under physiological hypoxia in early pregnant period, is involved in poor placentation in preeclampsia. Autophagy 2013; 9:303–316.
87. Teixeira PF, Cerca F, Santos SD, Saraiva MJ: Endoplasmic reticulum stress associated with extracellular aggregates. Evidence from transthyretin deposition in familial amyloid olyneuropathy. J Biol Chem 2006; 281:21998–22003.